Skip to content

A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredients

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506442-24-00
Acronym
C5091013
Enrollment
12
Registered
2023-10-13
Start date
2023-11-15
Completion date
2024-01-12
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronavirus disease 2019

Interventions

None listed

Sponsors

Pfizer Inc., Pfizer Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026